Gsk Share Discussion Threads

[montyhedge] 22/3/2018 04:00

Oh no, investors will now think dividend not sustainable if they bid 20 billion for Pfizer division. FT normally spot on with their contacts.

[philanderer] 22/3/2018 00:37

Financial Times

GlaxoSmithKline in pole position for $20bn Pfizer unit

GlaxoSmithKline is in pole position to win the race for the consumer healthcare business of US pharma giant Pfizer, after it beat a rival bid from Reckitt Benckiser.

Pfizer hopes to secure as much as $20bn for the unit, which sells branded over-the-counter products such as Advil painkillers, Centrum multivitamins and Caltrate calcium supplement.

[whatsup32] 21/3/2018 21:58

I’ll leave it.

[abdullla] 21/3/2018 21:19

When something doesn't sell then surely it loses its value and the price drops, just my commonsense, take it or leave it!

[whatsup32] 21/3/2018 21:00

Abdullah
Please explain

[abdullla] 21/3/2018 20:57

Good opportunity to get it on the cheap!

[whatsup32] 21/3/2018 20:51

This leaves Glaxo as the sole bidder ?

[woodhawk] 21/3/2018 19:25

Oh good, all the loonies are back - things must be about to look up. In the meantime, I'll continue to pocket the divis...only a couple of weeks to another payout and more than five times what I might in the bank (with less tax).

[abdullla] 21/3/2018 19:08

Emma is shambolic !she is now filtered .

[fangorn2] 21/3/2018 18:47

Emma is shambolic.

Share price evidences such

Woe betide she overpays for Pfizers consumer division.

[philanderer] 21/3/2018 14:19

FOCUS-GlaxoSmithKline prescribes commercial reboot for pharma division

[abdullla] 21/3/2018 09:56

So it's a heart attack with a double bypass!

[billionaire1] 21/3/2018 09:34

it seems to have bypassed abdulla also

[tradermichael] 21/3/2018 09:16

GSK is starting a Phase 3 combination study to evaluate whether its lupus drug Benlysta will work when combined with rituximab.

[abdullla] 20/3/2018 13:43

It would be a good deal at £12.50 on divi day for buyers!

[billionaire1] 20/3/2018 10:11

today is international day of happiness but it seems to have bypassed glaxo

[tradermichael] 20/3/2018 09:26

- and don't forget the Novartis option!

[montyhedge] 20/3/2018 09:22

I think share price will drift until we know who has one the bid for Pfizer consumer div. knock 50p off our price if it's us. But that could be good news for us reinvesting our dividend later on.

[tradermichael] 20/3/2018 09:03

GlaxoSmithKline has a lot riding on Shingrix, its new shingles vaccine. It's one of the key products CEO Emma Walmsley cited as growth drivers for the languishing company. And that launch just got a major boost from CVS.
The pharmacy chain said Monday that nearly 10,000 of its pharmacies in the U.S. now have the shingles immunization on store shelves and available for patients.
Shingrix won FDA approval and CDC backing last fall and it's one of three important new launches for GSK. Numerous studies have shown that the new vaccine offers stronger protection than Merck's older Zostavax and that Shingrix's protection lasts at least four years.
The vaccine is recommended for adults 50 and older in two doses spaced two to six months apart. CVS is offering GSK's new immunization at more than 9,800 pharmacies around the country, according to a new release. CVS says many insurers will cover the shots, including Medicare Part D.

The development follows a move by grocery chain Albertsons to stock the vaccine, announced last month, and that company's set of pharmacies is set to get a lot bigger with its recent deal to buy the rest of Rite-Aid. That deal gives Albertson's 4,900 locations in the U.S.

[abdullla] 20/3/2018 07:44

The GSK ceo was talking on BBC 10pm news about brexit.

[abdullla] 19/3/2018 15:51

Seeing ftse down 120 points reminds me of the Twin tower days,yes those were the days that still come back to haunt old memories !

[abdullla] 19/3/2018 11:09

All wars start after countries kick each other's embassies staff out !